RWM
MAIA icon

Ritholtz Wealth Management’s MAIA Biotechnology MAIA Stock Holding History

Ritholtz Wealth Management’s Portfolio MAIA Stock Details MAIA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$32.3K Hold
23,071
– – ﹤0.01% 1187
2025
Q4 		$35.3K Buy
+23,071
New +$30.1K ﹤0.01% 1117

Other funds holding MAIA

SCM
Solas Capital Management Darien, Connecticut $174M AUM 6.33% 1-Year Est. Return
Alyeska Investment Group
Alyeska Investment Group Chicago, Illinois $35.4B AUM 33.54% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
6CM
683 Capital Management New York $1.92B AUM 85.52% 1-Year Est. Return
CWM
Centric Wealth Management Chicago, Illinois $501M AUM 15.27% 1-Year Est. Return
CCC
Cable Car Capital San Francisco, California $289M AUM 26.33% 1-Year Est. Return
BL
Bleichroeder LP New York $579M AUM 94.36% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
VFT
Vanguard Fiduciary Trust Malvern, Pennsylvania $396B AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Ritholtz Wealth Management's MAIA Position: Q1 2026 in Review

Ritholtz Wealth Management held its MAIA Biotechnology (MAIA) position steady in Q1 2026 at 23,071 shares worth $32.3K. The position accounts for ﹤0.01% of the portfolio, ranked #1187.

Ritholtz Wealth Management first reported a position in MAIA in Q4 2025 and has held it in 2 quarters since. The position peaked at $35.3K in Q4 2025. 33 funds tracked by Wall St. Rank hold MAIA as of Q1 2026.

  • Ritholtz Wealth Management held 23,071 shares of MAIA Biotechnology worth $32.3K as of Q1 2026.
  • Ritholtz Wealth Management left its MAIA Biotechnology share count unchanged in Q1 2026.
  • MAIA Biotechnology made up ﹤0.01% of Ritholtz Wealth Management's portfolio in Q1 2026, its #1187 holding.
  • Ritholtz Wealth Management first reported a position in MAIA Biotechnology in Q4 2025 and has held it in 2 quarters since.
  • Ritholtz Wealth Management's MAIA Biotechnology position peaked at $35.3K in Q4 2025.
  • 33 funds tracked by Wall St. Rank held MAIA Biotechnology as of Q1 2026.

Based on Ritholtz Wealth Management's 13F filing for Q1 2026, filed 20 Apr 2026.